July 10, 2017
A New Jersey federal judge on Monday tossed Sanofi-Aventis' state consumer fraud law claim against Novo Nordisk over allegedly unlawful marketing of its competing diabetes medication, reasoning that the statute aims to protect customers, not competitors.